Abstract
New cases of Charcot foot are uncommon, but not so uncommon that the condition does not need to be considered by non-specialists. Once the diagnosis is considered, the person with a possible acute Charcot foot should avoid any weight-bearing on the affected foot and the condition should be assessed by an expert as soon as possible. The condition results from uncontrolled inflammation within the bones, joints and soft tissues of the foot and is likely to be mediated by a number of direct and indirect consequences of neuropathy. There is no specific treatment and management relies on the provision of effective off-loading to (1) splint the affected foot in order to curtail the process of inflammation and (2) protect the affected foot from the trauma of weight-bearing while the bones and joint are vulnerable. There is no agreement on the role of surgery in the active, inflammatory, phase and it should be adopted only by experienced experts in the field. When the active phase has entered remission, there may be a place for elective surgery to correct residual deformity. The person who has had a Charcot foot should remain under long-term review because of (1) the risk of secondary ulceration resulting from residual deformity, (2) the risk of contralateral disease and (3) to address the acknowledged reduction in long-term survival.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Jeffcoate WJ, Game F, Cavanagh PR. The role of pro-inflammatory cytokines in the cause of neuropathic osteoarthopathy (acute Charcot foot) in diabetes. Lancet. 2005;366:2058–61.
Game FL, Callow R, Jones GR, Edmonds ME, Jude EB, Rayman G, Jeffcoate WJ. Audit of acute Charcot’s disease in the UK: the CDUK study. Diabetologia. 2012;55:32–5.
Further Reading
Jeffcoate WJ, Game FL. New theories on the cause of the Charcot foot of diabetes. In: Frykberg R, editor. The Charcot foot and ankle. Towson: DTP; 2010.
Rogers LC, Frykberg RG, Armstrong DG, Boulton AJ, Edmonds M, Van GH, et al. The Charcot foot in diabetes. ADA consensus statement. Diabetes Care. 2011;34:2123–39.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Jeffcoate, W.J. (2023). Neuro-osteoarthropathy: The Charcot Foot—Pathology, Diagnosis, and Treatment. In: Shearman, C.P., Chong, P. (eds) Management of Diabetic Foot Complications. Springer, Cham. https://doi.org/10.1007/978-3-031-05832-5_12
Download citation
DOI: https://doi.org/10.1007/978-3-031-05832-5_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-05831-8
Online ISBN: 978-3-031-05832-5
eBook Packages: MedicineMedicine (R0)